CoChat

Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys

Open access
EUROASPIRE IV & V Investigators, Ferrannini, Giulia, De Bacquer, Dirk, Vynckier, Pieter, De Backer, Guy, Gyberg, Viveca, Kotseva, Kornelia, Mellbin, Linda, Norhammar, Anna, Tuomilehto, Jaakko, Wood, David, Rydén, Lars · 2021 · Cardiovascular Diabetology

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Background: Gender disparities in the management of dysglycaemia, defined as either impaired glucose tolerance (IGT) or type 2 diabetes (T2DM), in coronary artery disease (CAD) patients are a medical challenge. Recent data from two nationwide cohorts of patients suggested no gender difference as regards the risk for diabetes-related CV complications but indicated the presence of a gender disparity in risk factor management. The aim of this study was to investigate gender differences in screening for dysglycaemia, cardiovascular risk factor management and prognosis in dysglycemic CAD patients. Methods: The study population (n = 16,259; 4077 women) included 7998 patients from the ESC-EORP EUROASPIRE IV (EAIV: 2012–2013, 79 centres in 24 countries) and 8261 patients from the ESC-EORP EUROASPIRE V (EAV: 2016–2017, 131 centres in 27 countries) cross-sectional surveys. In each centre, patients were investigated with standardised methods by centrally trained staff and those without known diabetes were offered an oral glucose tolerance test (OGTT). The first of CV death or hospitalisation for non-fatal myocardial infarction, stroke, heart failure or revascularization served as endpoint. Median follow-up time was 1.7 years. The association between gender and time to the occurrence of the endpoint was evaluated using Cox survival modelling, adjusting for age. Results: Known diabetes was more common among women (32.9%) than men (28.4%, p < 0.0001). OGTT (n = 8655) disclosed IGT in 17.2% of women vs. 15.1% of men (p = 0.004) and diabetes in 13.4% of women vs. 14.6% of men (p = 0.078). In both known diabetes and newly detected dysglycaemia groups, women were older, with higher proportions of hypertension, dyslipidaemia and obesity. HbA1c was higher in women with known diabetes. Recommended targets of physical activity, blood pressure and cholesterol were achieved by significantly lower proportions of women than men. Women with known diabetes had higher risk for the endpoint than men (age-adjusted HR 1.22; 95% CI 1.04–1.43). Conclusions: Guideline-recommended risk factor control is poorer in dysglycemic women than men. This may contribute to the worse prognosis in CAD women with known diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12933-021-01233-6

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flowchart of the patients and their glycaemic classification according to the oral glucose tolerance test (OGTT). The dysglycemic study population is highlighted with yellow background. EA EUROASPIRE, IFG impaired fasting glucose, IGT impaired glucose tolerance, T2DM type 2 diabetes mellitus
Fig. 1 Flowchart of the patients and their glycaemic classification according to the oral glucose tolerance test (OGTT). The dysglycemic study population is highlighted with yellow background. EA EUROASPIRE, IFG impaired fasting glucose, IGT impaired glucose tolerance, T2DM type 2 diabetes mellitusCC BY · PubMed Central
Fig. 2 The distribution of glycaemic state divided by gender in the study population. IFG impaired fasting glucose, IGT impaired glucose tolerance, T2DM type 2 diabetes mellitus
Fig. 2 The distribution of glycaemic state divided by gender in the study population. IFG impaired fasting glucose, IGT impaired glucose tolerance, T2DM type 2 diabetes mellitusCC BY · PubMed Central
Fig. 3 Proportions and their overlap between screening with different methods [FPG ≥ 7 mmol/L, 2hPG mmol/L ≥ 7.8 mmol/L, HbA1c ≥ 6.5% (48 mmol/mol)] and their combinations in men and women with newly detected dysglycaemia (IGT or T2DM). 2 h-PG 2-h post-load glucose, FPG fasting plasma glucose, HbA1c glycated haemoglobin, IGT impaired glucose tolerance, T2DM type 2 diabetes mellitus
Fig. 3 Proportions and their overlap between screening with different methods [FPG ≥ 7 mmol/L, 2hPG mmol/L ≥ 7.8 mmol/L, HbA1c ≥ 6.5% (48 mmol/mol)] and their combinations in men and women with newly detected dysglycaemia (IGT or T2DM). 2 h-PG 2-h post-load glucose, FPG fasting plasma glucose, HbA1c glycated haemoglobin, IGT impaired glucose tolerance, T2DM type 2 diabetes mellitusCC BY · PubMed Central
Fig. 4 Proportion of patients with previously known T2DM and newly detected dysglycaemia reaching different blood pressure (a) and LDL-C (b) targets in the total cohort
Fig. 4 Proportion of patients with previously known T2DM and newly detected dysglycaemia reaching different blood pressure (a) and LDL-C (b) targets in the total cohortCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 1

  1. Geneva WHO, Estimates GH. Deaths by cause, age, sex, by country and by. Region. 2016;2000–2016:2018.

Cited by

See all 54

Metadata

Authors
EUROASPIRE IV & V Investigators, Ferrannini, G., De Bacquer, D., Vynckier, P., De Backer, G., Gyberg, V., Kotseva, K., Mellbin, L., Norhammar, A., Tuomilehto, J., Wood, D., & Rydén, L.
Affiliations
  • Karolinska Institutet (SE)
  • Ghent University (BE)
  • Ollscoil na Gaillimhe – University of Galway (IE)
  • Karolinska University Hospital (SE)
  • University of Helsinki (FI)
Corresponding author
Ferrannini, Giulia
Venue
Cardiovascular Diabetology
Published
2021-02-11
Volume
20
Issue
1
Pages
38-38
ISSN
1475-2840 (ISSN-L)
OpenAlex
W3128100027
Cited by
54
References
45
Citations by year
2026: 8 · 2025: 9 · 2024: 20 · 2023: 11 · 2022: 6
FWCI
8.21
Type
journal article
Language
en
Open access
Licence
Locations
  • Cardiovascular Diabetology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Työväentutkimus Vuosikirja (submittedVersion)
Funders
  • European Society of Cardiology
  • Karolinska Institute
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
gender differences, dysglycemia, coronary artery disease, impaired glucose tolerance, type 2 diabetes, cardiovascular risk management, cardiovascular prognosis, cardiovascular mortality, cardiovascular hospitalization, oral glucose tolerance test, HbA1c, cardiovascular risk stratification, sex differences in cardiovascular care
MeSH terms
Heart Disease Risk Factors, Glycemic Control, Aged, Blood Glucose, Coronary Artery Disease, Diabetes Mellitus, Type 2, Europe, Female, Glucose Tolerance Test, Hospitalization, Humans, Male, Middle Aged, Predictive Value of Tests, Primary Prevention, Prognosis, Sex Factors, Time Factors, Biomarkers, Prevalence, Glucose Intolerance, Risk Assessment, Health Care Surveys, Risk Reduction Behavior, Healthcare Disparities, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys. https://app.cochat.ai/papers/10.1186/s12933-021-01233-6
The paper
EUROASPIRE IV & V Investigators, Ferrannini, G., De Bacquer, D., Vynckier, P., De Backer, G., Gyberg, V., Kotseva, K., Mellbin, L., Norhammar, A., Tuomilehto, J., Wood, D., & Rydén, L. (2021). Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-021-01233-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.